Several epidemiological studies on the association between this polymorphism and breast cancer risk or IGF-I levels (Jernstrom et al, 2001a; Yu et al, 2001; Figer et al, 2002; Missmer et al, 2002; DeLellis et al, 2003) have yielded highly conflicting results. This evidence concerns the gene IGF1 and breast carcinoma.